Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine
https://doi.org/10.20996/1819-6446-2020-04-11
Abstract
The recent discussion about the dangers of using angiotensin-converting-enzyme (ACE) inhibitors and angiotensin II receptor antagonists (ARA) in patients with COVID-19 is analyzed in the article. There is controversy over the hypothesis that these drugs can be factors contributing to an unfavorable outcome of a viral disease, as well as the absence of any clinical evidence for this hypothesis. The opinion that withdrawal of ACE inhibitors and ARA in patients with COVID-19 may increase the risk of adverse outcomes is presented.
About the Author
S. Yu. Martsevich
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Russian Federation
Sergey Yu. Martsevich – MD, PhD, Professor, Head of Department of Preventive Pharmacotherapy
Petroverigsky per. 10, Moscow, 101990 RussiaReferences
1. Russian statistical yearbook. Moscow: Rosstat; 2019 (In Russ.)
2. Yu C.M. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82:140-4. DOI:10.1136/pgmj.2005.037515.
3. Xiong T.Y., Redwood S., Prendergast B., Chen M. Coronaviruses and cardiovascular system: acute and long-term complications. Eur Heart J. 2020; DOI:10.1093/eurheartj/ehaa231.
4. Libby P., Simon D.L. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103:1718-20. DOI:10.1161/01.cir.103.13.1718.
5. Fedson D.S., Rordam O.M. Testing Ebola patients: a “bottom up” approach using generic statins and angiotensin receptor blockers. Int J Infect Dis. 2015;36:80-4.
6. Fedson D.S., Opal S., Rordam O.M. Hiding in plain sight: an approach to treating patients with severe COVID-10 infection. mBio. 11:e00398-20. DOI:10.1128/mBio.00398-20.
7. Sommerstein R., Grani C. Rapid response: re: preventing a covid-19 pandemic: ACE inhibitors as a potential risk factor for fatal Covid-19. BMJ. 2020;368:m810.
8. Diaz J.H. Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19. J Travel Med. 2020 Mar 18. pii: taaa041. DOI:10.1093/jtm/taaa041.
9. Guan W., Ni Z., Liang W., et al. Clinical characteristics of coronavirus disease in China. N Engl J Med. 2020, February 28. DOI:10.1056/MEJMoa2002032.
10. Aronson J.K., Ferner R.E. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 [cited by April 14, 2020]. Available from: https://www.cebm.net/covid-19/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-receptor-blockers-in-covid-19/.
11. Aronson J.A., Ferner R.E. Drugs and the renin-angiotensin system in covid-19. BMJ. 2020;369:m1313. DOI:10.1136/bmj.m1313.
12. Sarzani R. Relationship between COVID-19 and rennin-angiotensin-aldosterone-system blockers: hasty speculations may be dangerous. BMJ. 2020;368:m810.
13. Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Disc Res. 2020. DOI:10.1002/ddr.21656.
14. Kuster G., Pfister O., Burkard T., et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Eur Heart J. 2020 Mar 20. pii: ehaa235. DOI:10.1093/eurheartj/ehaa235.
15. Vaduganathan M., Vardeny O., Michel T., et al. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020 Mar 30. DOI:10.1056/NEJMsr2005760.
16. Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers [cited by April 14, 2020]. Available from: https://www.escardio.org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-of-the-esc-council-on-hypertension-on-ace-inhibitors-and-ang.
Review
For citations:
Martsevich S.Yu. Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine. Rational Pharmacotherapy in Cardiology. 2020;16(2):273-276. (In Russ.) https://doi.org/10.20996/1819-6446-2020-04-11
Views: 701
Email this article 